13F-HR filed by Nan Fung Group Holdings Ltd
Nan Fung Group Holdings Ltd filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-13, with 42 holding rows worth $145,136,552.
- Accession
- 0001012975-23-000084
- Filer
- CIK 1782539
- Filed
- 2023-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A combination report, 42 entries on the cover page, a total value of $145,136,552 stated on the cover page (in dollars after the unit check, H1), rows summing to $145,136,552 with VALUE read as dollars as filed, 13F file number 028-21371. The quarter's positions are built on this report. The resolved quarter.
Other managers
- reports for this filerPivotal bioVenture Partners Investment Advisor LLC028-20630
- reports for this filerPivotal bioVenture Partners Fund I U.G.P., Ltd028-20631
- included managerPivotal bioVenture Partners Investment Advisor LLC028-20630
- included managerPivotal bioVenture Partners Fund I U.G.P., Ltd028-20631
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 225,688 | $44,347,692 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 119,196 | $24,101,431 | dollars as filed | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 368,665 | $20,313,442 | dollars as filed | |
| SEAGEN INC | 81181C104 | COM | 47,096 | $6,052,307 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 189,339 | $5,150,021 | dollars as filed | |
| EXSCIENTIA PLC | 30223G102 | ADS | 853,050 | $4,546,757 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 114,380 | $4,510,003 | dollars as filed | |
| SOMALOGIC INC | 83444K105 | COM | 1,696,558 | $4,258,361 | dollars as filed | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 113,950 | $2,985,490 | dollars as filed | |
| RANI THERAPEUTICS HLDGS INC | 753018100 | CMN | 493,584 | $2,912,146 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 34,391 | $2,762,285 | dollars as filed | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 12,022 | $2,644,119 | dollars as filed | |
| IVERIC BIO INC | 46583P102 | COM | 111,984 | $2,397,577 | dollars as filed | |
| EARGO INC | 270087109 | COM | 2,958,099 | $1,700,907 | dollars as filed | |
| BOLT BIOTHERAPEUTICS INC | 097702104 | COM | 1,166,952 | $1,517,038 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 50,616 | $1,483,049 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 93,750 | $1,450,313 | dollars as filed | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 136,655 | $1,117,838 | dollars as filed | |
| EXELIXIS INC COM | 30161Q104 | Stock | 64,200 | $1,029,768 | dollars as filed | |
| ENTRADA THERAPEUTICS INC COM | 29384C108 | Stock | 73,582 | $994,829 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 32,520 | $946,982 | dollars as filed | |
| GALERA THERAPEUTICS EQUICLASS EQUITY | 36338D108 | COMMON STOCK | 613,223 | $913,702 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 6,115 | $632,841 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 370,950 | $567,554 | dollars as filed | |
| FIBROGEN INC | 31572Q808 | COM | 34,106 | $546,378 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 25,606 | $538,494 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 78,720 | $532,147 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 4,168 | $509,038 | dollars as filed | |
| BIOMEA FUSION INC | 09077A106 | CMN | 60,000 | $505,800 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 29,984 | $477,345 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 41,950 | $472,777 | dollars as filed | |
| AFFIMED N V | N01045108 | COM | 372,472 | $461,865 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 1,110 | $420,501 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 1,182 | $343,076 | dollars as filed | |
| GITLAB INC CLASS A COM | 37637K108 | Stock | 6,910 | $313,990 | dollars as filed | |
| SATSUMA PHARMACEUTICALS INC | 80405P107 | COM | 177,900 | $160,110 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 19,622 | $140,494 | dollars as filed | |
| ABCELLERA BIOLOGICS INC COM | 00288U106 | Stock | 12,521 | $126,838 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 11,500 | $126,270 | dollars as filed | |
| SYNLOGIC INC | 87166L100 | COM | 68,634 | $52,162 | dollars as filed | |
| CERUS CORP | 157085101 | COM | 14,172 | $51,728 | dollars as filed | |
| INVITAE CORP | 46185L103 | COM | 11,337 | $21,087 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001012975-23-000084 | this filing | 2023-02-13 | acceptance time not in the bulk data set |